Jefferson Guillon

Jefferson Guillon is currently the UK QPPV and Head of Global Pharmacovigilance Agreements and Alliances at CSL, where they have been a key player since 2023. Prior to this, Jefferson held various roles at CSL, including Head of Pharmacovigilance and Risk Management Operations, and Head of Outsourced Managed Services from 2018 to 2022. Their experience also includes positions as Associate Director of Pharmacovigilance at Mapi Group and Pharmacovigilance Manager at Alliance Pharmaceuticals Ltd. Jefferson began their career as a QC Analyst at Cardinal Health and 3M Pharmaceuticals in 2005. They earned their degree from De Montfort University between 2003 and 2005.